Class information for:
Level 1: AS03//UNIVERSAL VACCINE//HETEROSUBTYPIC IMMUNITY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1666 2465 42.2 79%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
60 28358 INFLUENZA//AVIAN INFLUENZA//H5N1

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 AS03 Author keyword 38 86% 1% 19
2 UNIVERSAL VACCINE Author keyword 33 77% 1% 23
3 HETEROSUBTYPIC IMMUNITY Author keyword 32 69% 1% 27
4 M2E Author keyword 31 66% 1% 29
5 MF59 Author keyword 31 56% 2% 38
6 INFLUENZA VACCINE Author keyword 21 14% 5% 134
7 H5N1 Author keyword 18 14% 5% 116
8 PANDEMIC Author keyword 16 11% 5% 135
9 INFLUENZA Address 15 10% 6% 138
10 CRUCELL VACCINE Address 15 88% 0% 7

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 AS03 38 86% 1% 19 Search AS03 Search AS03
2 UNIVERSAL VACCINE 33 77% 1% 23 Search UNIVERSAL+VACCINE Search UNIVERSAL+VACCINE
3 HETEROSUBTYPIC IMMUNITY 32 69% 1% 27 Search HETEROSUBTYPIC+IMMUNITY Search HETEROSUBTYPIC+IMMUNITY
4 M2E 31 66% 1% 29 Search M2E Search M2E
5 MF59 31 56% 2% 38 Search MF59 Search MF59
6 INFLUENZA VACCINE 21 14% 5% 134 Search INFLUENZA+VACCINE Search INFLUENZA+VACCINE
7 H5N1 18 14% 5% 116 Search H5N1 Search H5N1
8 PANDEMIC 16 11% 5% 135 Search PANDEMIC Search PANDEMIC
9 PREPANDEMIC 14 100% 0% 7 Search PREPANDEMIC Search PREPANDEMIC
10 HEMAGGLUTININ 13 11% 4% 110 Search HEMAGGLUTININ Search HEMAGGLUTININ

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MATRIX PROTEIN 2 163 86% 3% 82
2 MF59 ADJUVANTED INFLUENZA 139 75% 4% 100
3 HETEROSUBTYPIC IMMUNITY 102 64% 4% 99
4 H5N1 VACCINE 81 71% 3% 65
5 A H5N1 VACCINE 67 87% 1% 33
6 I RANDOMIZED TRIAL 61 95% 1% 20
7 A DUCK SINGAPORE 97 H5N3 VACCINE 56 73% 2% 43
8 CROSS REACTIVE IMMUNITY 56 74% 2% 42
9 A VIRUS 50 11% 18% 447
10 HEMAGGLUTININ STALK ANTIBODIES 49 94% 1% 17

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Advances in Universal Influenza Virus Vaccine Design and Antibody Mediated Therapies Based on Conserved Regions of the Hemagglutinin 2015 7 88 76%
Advances in the development of influenza virus vaccines 2015 4 203 73%
Toward a Universal Influenza Virus Vaccine: Prospects and Challenges 2013 57 61 77%
Influenza Neuraminidase as a Vaccine Antigen 2015 4 77 49%
Inactivated and Adjuvanted Influenza Vaccines 2015 3 130 55%
Virus-specific T cells as correlate of (cross-)protective immunity against influenza 2015 2 102 64%
CURRENT CONCEPTS Influenza Vaccines for the Future 2010 113 45 60%
Safety and effectiveness of MF-59 adjuvanted influenza vaccines in children and adults 2015 1 10 80%
Eliciting broadly protective antibody responses against influenza 2014 7 46 76%
Influenza vaccine immunology 2011 56 77 69%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INFLUENZA 15 10% 5.6% 138
2 CRUCELL VACCINE 15 88% 0.3% 7
3 JEBSEN INFLUENZA VACCINE 11 78% 0.3% 7
4 VIRAL PROD 8 14% 2.2% 55
5 VIRAL PSEUDOTYPE UNIT 8 60% 0.4% 9
6 UNIT ANTIVIRAL IMMUN GENET THER Y 7 53% 0.4% 9
7 NEW YORK INFLUENZA EXCELLENCE 6 71% 0.2% 5
8 INFLUENZA BRANCH 4 16% 1.0% 25
9 SCI TECHNOL DR CESAR MILSTEIN 4 75% 0.1% 3
10 VACCINE EVALUAT 4 15% 1.0% 25

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000220312 LIVE ATTENUATED INFLUENZA VACCINE//LAIV//OCULO RESPIRATORY SYNDROME
2 0.0000159306 HEMAGGLUTININ//ANTIGENIC DRIFT//D222G
3 0.0000139675 CHAIR BIOPROC ENGN//VACCINE PRODUCTION//RESIDUAL DNA
4 0.0000120701 LIVE ATTENUATED INFLUENZA VACCINE//INFLUENZA VACCINE//INFLUENZA
5 0.0000116088 INFLUENZACHINESE INFLUENZA//IMMUNOL PATHOGENESIS BRANCH//INT INFECT IMMUN
6 0.0000101282 AVIAN INFLUENZA//AVIAN INFLUENZA VIRUS//H5N1
7 0.0000097047 H1N2//SWINE INFLUENZA VIRUS//SWINE INFLUENZA
8 0.0000076390 VIROSOMES//FUSOGENIC LIPOSOME//VIROSOME
9 0.0000075858 PANDEMIC//SCHOOL CLOSURE//PANDEMIC INFLUENZA
10 0.0000074148 M2 CHANNEL//M2 PROTON CHANNEL//M2 PROTEIN